mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells

Activating mutations of the FLT3 gene mediate leukemogenesis, at least in part, through activation of PI3K/AKT. The mammalian target of rapamycin (mTOR)-Raptor signaling pathway is known to act downstream of AKT. Here we show that the mTOR effectors, 4EBP1, p70S6K and rpS6, are highly activated in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Weina, Drakos, Elias, Grammatikakis, Ioannis, Schlette, Ellen J, Li, Jiang, Leventaki, Vasiliki, Staikou-Drakopoulou, Efi, Patsouris, Efstratios, Panayiotidis, Panayiotis, Medeiros, L Jeffrey, Rassidakis, George Z
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993677/
https://www.ncbi.nlm.nih.gov/pubmed/21067588
http://dx.doi.org/10.1186/1476-4598-9-292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993677/
https://www.ncbi.nlm.nih.gov/pubmed/21067588
http://dx.doi.org/10.1186/1476-4598-9-292

Ejemplares similares